Immunohistochemical Profile of p62/SQSTM1/Sequestosome-1 in Human Low- and High-Grade Intracranial Meningiomas.


Journal

Analytical cellular pathology (Amsterdam)
ISSN: 2210-7185
Titre abrégé: Anal Cell Pathol (Amst)
Pays: United States
ID NLM: 101541993

Informations de publication

Date de publication:
2024
Historique:
received: 09 08 2023
revised: 25 06 2024
accepted: 15 07 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: epublish

Résumé

Among autophagic-related proteins, p62/SQSTM1/Sequestosome-1 represents a relevant actor in cellular proliferation and neoplastic growth. Although, recently, p62 expression has been analyzed in different neurodegenerative and glial neoplastic diseases, no available information have been reported in meningiomas, which have an high epidemiological relevance being the second most common category of intracranial tumors after gliomas. Generally meningiomas have a benign behavior, but their recurrence is not uncommon mainly when atypical or anaplastic varieties occur. However, intranuclear vacuoles have been ultrastructurally observed in meningiomas, and they were labelled by p62 antibodies. Therefore, in the present study, we have investigated p62 immunohistochemical pattern in a cohort of 133 cases representative of low- and high-grade meningiomas, to verify if p62 expression may be related to clinicopathological data, thus achieving a potential prognostic role. The p62 immunoexpression was frequently found in the nucleus and cytoplasm of neoplastic elements, and utilizing an intensity-distribution score, 55 (41.3%) cases were considered as high expressors while 78 (58.7%) cases were instead recorded as low expressors. Fifteen cases exhibited recurrences of the disease, 14 of which were codified as high expressors. Moreover, a direct relationship between p62 and Mib-1 immunoexpression as well as between p62 and neoplastic grade have been documented. Finally, we suggest that impaired autophagic flux with an increase in p62 expression may be involved in the activation of NRF2 also contributing in the development of recurrence in meningioma patients.

Identifiants

pubmed: 39131899
doi: 10.1155/2024/5573892
pmc: PMC11315968
doi:

Substances chimiques

Sequestosome-1 Protein 0
SQSTM1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5573892

Informations de copyright

Copyright © 2024 Antonio Ieni et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Auteurs

Antonio Ieni (A)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Cristina Pizzimenti (C)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, Neurosurgery University of Messina, Viale Gazzi, Messina 98125, Italy.

Vincenzo Fiorentino (V)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Mariausilia Franchina (M)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Antonino Germanò (A)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, Neurosurgery University of Messina, Viale Gazzi, Messina 98125, Italy.

Giovanni Raffa (G)

Department of Biomedical, Dental, Morphological and Functional Imaging Sciences, Neurosurgery University of Messina, Viale Gazzi, Messina 98125, Italy.

Maurizio Martini (M)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Guido Fadda (G)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Giovanni Tuccari (G)

Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi" Section of Pathology University of Messina, Messina 98125, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH